Holen Sie sich die Stockscreener-App
2.50
7.12%
-0.10
Schlusskurs vom Vortag:
$2.60
Offen:
$2.65
24-Stunden-Volumen:
9,762
Relative Volume:
0.56
Marktkapitalisierung:
$16.46M
Einnahmen:
$22.38M
Nettoeinkommen (Verlust:
$-13.33M
KGV:
-0.5519
EPS:
-4.53
Netto-Cashflow:
$-8.06M
1W Leistung:
-15.85%
1M Leistung:
-15.85%
6M Leistung:
-61.51%
1J Leistung:
-49.16%
1-Tages-Spanne:
$2.25
$2.674
1-Wochen-Bereich:
$2.19
$2.9682
52-Wochen-Spanne:
$2.19
$7.5498
Ezfill Holdings Inc Stock (EZFL) Company Profile
Firmenname
Ezfill Holdings Inc
Sektor
Branche
Telefon
305-791-1169
Adresse
67 NW 183RD ST, MIAMI
Vergleichen Sie EZFL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| EZFL | 2.50 | 16.46M | 22.38M | -13.33M | -8.06M | -4.53 |
| CRM | 338.32 | 324.58B | 36.47B | 5.63B | 11.46B | 1.59 |
| SAP | 236.25 | 274.15B | 36.09B | 2.98B | 7.67B | 5.2918 |
| NOW | 1,049.08 | 215.85B | 10.46B | 1.34B | 3.35B | 7.72 |
| INTU | 679.96 | 189.18B | 16.29B | 2.96B | 4.63B | 8.44 |
| UBER | 69.90 | 147.99B | 41.96B | 4.40B | 5.96B | -0.22 |
Ezfill Holdings Inc Aktie (EZFL) Neueste Nachrichten
EzFill stock hits 52-week low at $2.19 amid market challenges By Investing.com - Investing.com South Africa
EZFill Holdings Inc. announced that it has received $0.2 million in funding - Marketscreener.com
EzFill stock hits 52-week low at $2.19 amid market challenges - Investing.com
EzFill secures $181.5K loan with NextNRG Holding By Investing.com - Investing.com UK
EzFill Holdings Reports Strong Q3 2024 Growth - TipRanks
EZFLEzFill Holdings, Inc. Latest Stock News & Market Updates - StockTitan
EzFill Announces 2024 Third Quarter Financial Results - GlobeNewswire
EzFill Q3 Revenue Climbs 13%, Delivers Record 1.87M Gallons Amid Strong Growth | EZFL Stock News - StockTitan
Yoshi Mobility Agrees to Sell Its Fleet Fueling Operation to EZFill Holdings - NGT News
Frist's Yoshi Mobility sells fuel division - The Business Journals
EzFill to acquire Yoshi fueling division, eyes national expansion - Investing.com
EzFill Fueling up to Expand Nationally Enters into LOI for the Acquisition of Yoshi Mobility’s Fuel Division - GlobeNewswire
Yoshi Mobility goes green, spins off fueling division - StockTitan
EZFill Holdings Inc. signed a letter of intent to acquire Fueling division of Yoshi, Inc. - Marketscreener.com
EzFill Mobilizes Fleet Actively Supporting Residents and Businesses Impacted By Major Hurricanes Helene and Milton - GlobeNewswire
EzFill Mobilizes Fleet Actively Supporting Residents and Businesses Impacted By Major Hurricanes Helene and - EIN News
EzFill Holdings revises share exchange in NextNRG acquisition - Investing.com
EzFill Holdings revises share exchange in NextNRG acquisition By Investing.com - Investing.com Canada
EZFill Holdings Inc. (NASDAQ:EZFL) Short Interest Down 56.5% in September - Defense World
FDA Approves Miplyffa for Niemann-Pick Disease, Type C - MyChesCo
FDA Approves Miplyffa for Ultra Rare Niemann-Pick Disease Type C - Managed Healthcare Executive
FDA approves Zevra’s Miplyffa for Niemann-Pick disease type C treatment - World Pharmaceutical Frontiers
EzFill holdings CTO Avishai Vaknin sells shares worth $2300 By Investing.com - Investing.com South Africa
EzFill holdings CTO Avishai Vaknin sells shares worth $2300 - Investing.com
Ezzaty Abdullah admits to be delivering her baby soon - Yahoo Lifestyle Singapore
FDA approves Zevra Therapeutics’ Miplyffa for Niemann-Pick disease - Pharmaceutical Technology
FDA clears first drug for Niemann-Pick disease - pharmaphorum
Zevra’s Miplyffa wins first FDA approval in Niemann-Pick type C - BioWorld Online
EzFill Holdings (NASDAQ:EZFL) Stock Quotes, Forecast and News Summary - Benzinga
After prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa - FiercePharma
First Drug Approved for Niemann-Pick Disease Type C - Medpage Today
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease - Benzinga
Arimoclomol Becomes First FDA Approved Treatment for Neimann-Pick Disease Type C - Pharmacy Times
FDA approves first Niemann-Pick disease, type C treatment - The Pharma Letter
FDA approves arimoclomol as first drug to treat Neimann-Pick disease, type C - Contemporary Pediatrics
EZFill Holdings Inc. (NASDAQ:EZFL) CTO Sells $20,550.00 in Stock - Defense World
EzFill holdings CTO Avishai Vaknin sells shares worth nearly $30k By Investing.com - Investing.com South Africa
EzFill holdings CTO Avishai Vaknin sells shares worth nearly $30k - Investing.com India
Extra Storage rises on Jefferies upgrade - XM
EzFill holdings CTO Avishai Vaknin sells shares worth $29,180 - Investing.com India
EzFill holdings CTO Avishai Vaknin sells shares worth $29,180 By Investing.com - Investing.com Australia
Correction to Eli Lilly Gets FDA Approval for Eczema Treatment Article - Morningstar
Eli Lilly Gets FDA Approval for Eczema Treatment Ebglyss - MarketWatch
FDA Approves Eli Lilly's Drug for Eczema - Newsmax
Insider Sale: CTO Avishai Vaknin Sells Shares of EzFill Holdings Inc (EZFL) By GuruFocus - Investing.com Canada
EzFill Holdings CTO Avishai Vaknin sells $74,862 in company stock By Investing.com - Investing.com Canada
EzFill Holdings CTO Avishai Vaknin sells $74,862 in company stock - Investing.com
EzFill holdings CTO Avishai Vaknin sells shares worth over $15k - Investing.com
EzFill regains compliance with Nasdaq's equity rule - Investing.com
EzFill Holdings Regains Nasdaq Compliance, Faces Monitoring - TipRanks
EzFill Holdings, Inc. Regains Compliance with NASDAQ Listing Standard - GlobeNewswire
Finanzdaten der Ezfill Holdings Inc-Aktie (EZFL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ezfill Holdings Inc-Aktie (EZFL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Vaknin Avishai | Chief Technology Officer |
Sep 20 '24 |
Sale |
3.45 |
5 |
17 |
65,977 |
| Vaknin Avishai | Chief Technology Officer |
Sep 17 '24 |
Sale |
4.20 |
5,061 |
21,244 |
68,933 |
| Vaknin Avishai | Chief Technology Officer |
Sep 18 '24 |
Sale |
3.72 |
2,246 |
8,354 |
66,626 |
3.15%
1.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):